Skip to content
NASDAQ · SERVICES-MISC HEALTH & ALLIED SERVICES, NEC · MID CAP

Viemed Healthcare, Inc. VMD

8 fiscal years on record · USD · FY2025 reported · SEC filings only
$270.3M
▲ 20.5% YoY
$14.9M
▲ 32.6% YoY
$11.9M
▲ 805.2% YoY

Slide the table for earlier years · "·" marks a figure not available in our data for that year.

In brief

What this company does

Viemed Healthcare, Inc., through its subsidiaries, provides home medical equipment and post-acute healthcare services in the United States, with a focus on respiratory, chronic care, and women's health products and services. Its services include respiratory disease management through the rental of various home medical equipment devices, neuromuscular care, in-home sleep testing and sleep apnea treatment, oxygen therapy, the sale of associated supplies, women's health products and services, and healthcare staffing services. The Company serves patients in all 50 states of the United States. As of December 31, 2025, the Company employed 401 licensed respiratory therapists, representing approximately 29% of the Company-wide employee count. At December 31, 2025, Viemed had 1,382 permanent employees, in addition to temporary employees and independent contractors engaged through its healthcare staffing and recruitment services to supplement the workforce needs of third-party healthcare facilities. Monthly rental revenue from ventilators represented approximately 51% and 56% of revenue for 2025 and 2024, respectively, and revenues from Medicare and Medicaid accounted for 40% and 43% of revenue for those years, respectively. Viemed Healthcare, Inc. is a holding company incorporated in British Columbia under the Business Corporations Act in December 2016.

Written from the business description in Viemed Healthcare, Inc.'s annual report to the U.S. Securities and Exchange Commission, filed 4 March 2026. Every sentence was checked against that document before publication.

Growth

USD 270.3M
Revenue, FY2025 · full 8-year series below
Revenue $M Net income $M
FY2025 · Revenue 270.3 · Net income 14.9
100M200M
2018202120242025
Compound annual growth
+24.9%
+15.5%
+33.9%
−13.9%
+32.2%
−13.9%
3 yrs
5 yrs
10 yrs
15 yrs

Revenue compounded at +15.5% a year over the five years to FY2025.

Compound annual rates per period — left blank where that exact year isn't on file, the series crosses a loss, or (per-share rows) a split falls inside the window.

Profitability

6 cents
of every revenue dollar became profit
Operating margin Net margin
FY2025 · Operating 8.5% · Net 5.7%
10%20%
201820212025
ROE
FY2025 · ROE 10.9%
20%40%
201820212025
Three returns, three denominators.

Each USD of equity produced 11 cents of profit this year.

Cash & shareholders

USD 11.8M
returned in FY2025 · dividends + net buybacks
Free cash flow $M
FY2025 · FCF 11.9
10M20M
201820212025
Net buybacks $M Dividends $M
FY2025 · Dividends · · Net buybacks 11.8
5M10M-1M-2M
20182019202020212022202320242025

USD 11.8M in buybacks — 79% of the year's profit went back to shareholders.

Total assetsUSD 199.2M
EquityUSD 141.5M
CashUSD 13.5M
Gross debtUSD 12.4M
Net debtUSD -1.1M
Current ratio1.18×

The company holds more cash than debt.

The 8-year record

8 fiscal years
Every figure from documents filed with the SEC · USD
row low → row highnegative—not applicable◌not available in our data
VMD, 8-year financial record
Metric 20252024202320222021202020192018
Revenue $B0.30.20.20.10.10.10.10.1
Operating income $B0.00.00.00.00.00.00.00.0
EBITDA $B0.10.00.00.00.00.00.00.0
Income tax $B0.00.00.00.00.0−0.00.00.0
Net income $B0.00.00.00.00.00.00.00.0
Free cash flow $B0.00.00.00.00.00.00.00.0
EPS, diluted $0.370.280.250.160.220.780.210.24
Dividend / sh $◌◌◌◌◌◌◌◌
Payout % — not applicable: no dividend————————
ROE %10.99.29.76.510.350.322.429.2
Shares out B0.040.040.040.040.040.040.040.04

Slide the table for earlier years. "—" not applicable · "◌" not available in our data.

More in this sector

Other companies filing in the same sector

Provenance

Company facts, as filed

How we verify · 0 failures in 40 reconciliationsAUDITED

Reconciled in 8 of the 8 fiscal years we could check. 22 checks were skipped: the balance sheet is not tagged before 2018. 11 checks were skipped: EPS is not tagged before 2018. 11 checks were skipped: revenue is not tagged before 2018.

EPS recomputationBalance-sheet identityGross profitBalance-sheet liquidityCurrency consistency0 failures
ActivityServices-Misc Health & Allied Services, NEC
Listed onNASDAQ
Incorporated inoutside the United States — SEC code A1
Fiscal year endsDecember 31
Data on record since2018

Share this section

Download image